Journal
FUTURE MICROBIOLOGY
Volume 16, Issue 8, Pages -Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/fmb-2020-0303
Keywords
apolipoprotein A-I; innate immunity; Leishmania; trypanosome lytic factor
Categories
Funding
- National Institute for Medical Research Development (NIMAD), Tehran, Iran [963564]
Ask authors/readers for more resources
Apolipoprotein A-I (apo A-I) is the main component of the Trypanosome lytic factor (TLF) which aids in host immunity against Trypanosoma and Leishmania. Studies have shown adaptive mechanisms in TLF-resistant Trypanosoma species. It is hypothesized that Leishmania parasites may express apo A-I to evade the host immune system.
Apolipoprotein A-I (apo A-I) represents the main component of the Trypanosome lytic factor (TLF) which contributes to the host innate immunity against Trypanosoma and Leishmania. These parasites use complex and multiple strategies such as molecular mimicry to evade or subvert the host immune system. Previous studies have highlighted the adaptation mechanisms of TLF-resistant Trypanosoma species. These data might support the hypothesis that Leishmania parasites (amastigote forms in macrophages) might express apo A-I to bypass and escape from TLF action as a component of the host innate immune responses. The anti-inflammatory property of apo A-I is another mechanism that supports our idea that apo A-I may play a role in Leishmania parasites allowing them to bypass the host innate immune system.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available